Your browser doesn't support javascript.
loading
Patient experiences align with the familial hypercholesterolemia global call to action.
Jones, Laney K; Walters, Nicole; Brangan, Andrew; Ahmed, Catherine D; Wilemon, Katherine A; Campbell-Salome, Gemme; Rahm, Alanna K; Gidding, Samuel S; Sturm, Amy C.
Afiliação
  • Jones LK; Genomic Medicine Institute, Geisinger, Danville, PA, United States of America.
  • Walters N; Heart and Vascular Institute, Geisinger, Danville, PA, United States of America.
  • Brangan A; Genomic Medicine Institute, Geisinger, Danville, PA, United States of America.
  • Ahmed CD; Genomic Medicine Institute, Geisinger, Danville, PA, United States of America.
  • Wilemon KA; Family Heart Foundation, Pasadena, CA, United States of America.
  • Campbell-Salome G; Family Heart Foundation, Pasadena, CA, United States of America.
  • Rahm AK; Genomic Medicine Institute, Geisinger, Danville, PA, United States of America.
  • Gidding SS; Genomic Medicine Institute, Geisinger, Danville, PA, United States of America.
  • Sturm AC; Genomic Medicine Institute, Geisinger, Danville, PA, United States of America.
Am J Prev Cardiol ; 10: 100344, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35517872
ABSTRACT

Objective:

To explore alignment of perspectives from individuals and families with familial hypercholesterolemia (FH) to the FH Global Call to Action recommendations.

Methods:

Interviews and focus groups were conducted with individuals and families with FH from multiple U.S. health systems and the Family Heart Foundation community to capture lived experiences and to identify barriers to diagnosis, cascade testing, and treatment. Participant perspectives were examined and classified, according to their alignment to recommendations of the FH Global Call to Action.

Results:

A total of 75 lived experiences were analyzed. Participants were majority female, mostly white, older, and well-educated. Participants most frequently mentioned recommendations were family-based care (84%) and screening, testing, & diagnosis (84%), followed by treatment (69%), advocacy (60%), cost & value (59%), awareness (56%), research & registries (43%), and severe & homozygous FH (11%). An average of 4.65 (SD 1.76) recommendations were mentioned.

Conclusions:

The FH Global Call to Action was driven by the persistent unmet needs of those living with FH in receiving a timely diagnosis, appropriate care, and support to prevent early morbidity and mortality. Patient- and family-centric perspectives suggest the FH Global Call to Action captures these concerns. Acting on recommendations, particularly improvements in screening and family-based care, will address patient, and public health, concerns.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Ano de publicação: 2022 Tipo de documento: Article